RRP7A links primary microcephaly to dysfunction of ribosome biogenesis, resorption of primary cilia, and neurogenesis.
Muhammad FarooqLouise LindbækNicolai KroghCanan DoganliCecilie KellerMaren MönnichAndré Brás GonçalvesSrinivasan SakthivelYuan MangAmbrin FatimaVivi Søgaard AndersenMuhammad Sajid HussainHans EibergLars HansenKlaus Wilbrandt KjaerJay GopalakrishnanLotte Bang PedersenKjeld MøllgårdHenrik NielsenShahid M BaigNiels TommerupSøren Tvorup ChristensenLars Allan LarsenPublished in: Nature communications (2020)
Primary microcephaly (MCPH) is characterized by reduced brain size and intellectual disability. The exact pathophysiological mechanism underlying MCPH remains to be elucidated, but dysfunction of neuronal progenitors in the developing neocortex plays a major role. We identified a homozygous missense mutation (p.W155C) in Ribosomal RNA Processing 7 Homolog A, RRP7A, segregating with MCPH in a consanguineous family with 10 affected individuals. RRP7A is highly expressed in neural stem cells in developing human forebrain, and targeted mutation of Rrp7a leads to defects in neurogenesis and proliferation in a mouse stem cell model. RRP7A localizes to centrosomes, cilia and nucleoli, and patient-derived fibroblasts display defects in ribosomal RNA processing, primary cilia resorption, and cell cycle progression. Analysis of zebrafish embryos supported that the patient mutation in RRP7A causes reduced brain size, impaired neurogenesis and cell proliferation, and defective ribosomal RNA processing. These findings provide novel insight into human brain development and MCPH.
Keyphrases
- intellectual disability
- cell cycle
- neural stem cells
- cell proliferation
- cerebral ischemia
- autism spectrum disorder
- stem cells
- zika virus
- oxidative stress
- endothelial cells
- resting state
- mesenchymal stem cells
- subarachnoid hemorrhage
- nucleic acid
- multiple sclerosis
- bone marrow
- cell therapy
- bone loss
- density functional theory